COVID-19
Researchers from Hospital de Especialidades in Monterrey, Mexico, have identified key factors that increase the risk of severe pneumonia and mortality in patients with COVID-19 and diabetes mellitus (DM). The study, published in Clinical Diabetology, found that in-hospital hyperglycemia and the use of sliding scale insulin regimen significantly increased the
Tuberculosis
Researchers at the Texas Biomedical Research Institute have made significant strides in developing a new vaccine against Mycobacterium tuberculosis, the pathogen responsible for tuberculosis (TB). According to a recent study published in Jci Insight, the new vaccine has shown impressive results in protecting nonhuman primates against lethal TB challenge. The
COVID-19
A recent study from investigators at the Karolinska Institute in Stockholm, Sweden, has shed light on the importance of mucosal IgA in preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections. The research, published in the journal Vaccine, highlights the significance of mucosal vaccines and consistent methodologies for assessing mucosal
Autism
Pediatricians such as Dr. Nola Jean Ernest, who has been practicing in a rural southeastern corner of Alabama for over a decade, are the most trusted source of vaccine information for parents. A Washington Post-KFF poll found that 85% of parents trust their child's pediatrician on vaccines, a
Autism
President Trump and members of his administration announced their belief that a root cause of Autism Spectrum Disorder (ASD) is acetaminophen, citing a study that observed a correlation between acetaminophen exposure and infant neurological status. However, the majority of research suggests that vaccines do not cause autism, and the claim
COVID-19
A recent breakthrough in gene therapy has been reported by researchers from the Royal Melbourne Institute of Technology - RMIT University, as they delve into the intricacies of ionizable lipid nanoparticles (LNPs) used in mRNA vaccines. By applying cutting-edge techniques such as time-resolved synchrotron radiation small-angle X-ray scattering (SAXS), the
COVID-19
A recent report from Saskatoon, Canada, has published research findings on the safety and immunogenicity of a recombinant protein vaccine for COVID-19. The study, conducted by a team of researchers at the University of Saskatchewan, aimed to assess the safety and immunogenicity of a vaccine composed of the S1 subunit
Vaccines
A nationwide effort to eradicate poliovirus has achieved significant progress, with over 43.3 million children vaccinated in just five days. The National Emergency Operations Centre (NEOC) has reaffirmed its commitment to continued joint efforts to ensure the complete eradication of poliovirus from Pakistan. The ongoing national campaign aims to
Vaccines
RNA-based immunotherapies have gained significant attention in recent years due to their potential in reprogramming the immune system to combat cancer. A recent study published in Nature Biomedical Engineering has made groundbreaking discoveries that have led to the development of a new class of RNA therapeutics called Universal Immune Fortifying
Vaccines
A team of researchers from the University College Dublin has launched a scathing critique of the European Commission's centralized procurement approach for COVID-19 vaccines, highlighting transparency deficits, accountability gaps, and anticompetitive practices by vaccine producers that undermine equitable access. The study proposes a novel framework, FACER, which integrates
Vaccines
Research by the University of Michigan has shed new light on the "last-mile logistics" of vaccine infrastructure in the US. By examining the early phases of COVID-19 vaccination distribution among older adults in Florida, the study reveals the complexities of distributing vaccines to their intended end-consumers. The research
Vaccines
Researchers from KTO Karatay University in Turkey have made a significant advancement in mRNA vaccine development, designing a novel vaccine that incorporates a valine-enhanced lipid nanoparticle-coated mRNA targeting the SARS-CoV-2 S-RBD antigen. This innovative vaccine demonstrates improved stability and comprehensive characterization, paving the way for further development and testing. Key
